HIGHLIGHTS
- who: Wang Yin and collaborators from the Deakin University, Geelong, VIC, Australia have published the research work: Inhibition of Autophagy Promotes the Elimination of Liver Cancer Stem Cells by CD133 Aptamer-Targeted Delivery of Doxorubicin, in the Journal: (JOURNAL)
- what: In this study, the anti-hepatocellular carcinoma stem_cell effect of the combined treatment of CD133 aptamer-DOX and autophagy inhibitors was explored.
SUMMARY
Accumulating evidence has shown that a small subset of liver cancer cells, termed liver tumor-initiating cells or liver cancer stem_cells, are responsible for the initiation, propagation, metastasis . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.